Patents by Inventor Gita Natarajan Shankar

Gita Natarajan Shankar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7914767
    Abstract: A composition for oral radionuclide chelation therapy comprises a DTPA chelate selected from Zn-DTPA and Ca-DTPA and a permeation enhancer that preferentially increases jejunal uptake of the DTPA chelate. The composition has a DTPA chelate bioavailability of at least 10% of the chelate when orally administered to a mammal.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: March 29, 2011
    Assignee: SRI International
    Inventors: Gita Natarajan Shankar, Helen Jaber Parish
  • Patent number: 7592021
    Abstract: Formulations and methods for transmucosal delivery of a beneficial agent are described in which a pH-responsive component and a temperature-responsive component are combined and applied to a mucous membrane. The temperature-responsive component is a component that, in aqueous solutions, is capable of undergoing a temperature-dependent sol to gel phase transition. The formulations may be characterized as having bioadhesive properties, and are suitable for delivery of a variety of beneficial agents.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: September 22, 2009
    Assignee: SRI International
    Inventors: Gita Natarajan Shankar, Rae Lyn Burke
  • Publication number: 20090111736
    Abstract: An orally bioavailable pharmaceutical composition comprises at least 40% (w/w) vancomycin; a permeation enhancer component comprising 0.1 to 10.0% (w/w) of a polyoxyethylene sorbitan fatty acid ester; and a particulate carrier onto which the permeation enhancer component is adsorbed.
    Type: Application
    Filed: October 29, 2007
    Publication date: April 30, 2009
    Inventor: Gita Natarajan Shankar
  • Publication number: 20080207745
    Abstract: A composition for oral treatment of visceral leishmaniasis comprises paromomycin and a permeation enhancer that increases oral bioavailability of the paromomycin to at least 20%.
    Type: Application
    Filed: February 24, 2007
    Publication date: August 28, 2008
    Inventors: Gita Natarajan Shankar, Helen Jaber Parish
  • Publication number: 20070196273
    Abstract: A composition for oral radionuclide chelation therapy comprises a DTPA chelate selected from Zn-DTPA and Ca-DTPA and a permeation enhancer that preferentially increases jejunal uptake of the DTPA chelate. The composition has a DTPA chelate bioavailability of at least 10% of the chelate when orally administered to a mammal.
    Type: Application
    Filed: February 14, 2007
    Publication date: August 23, 2007
    Inventors: Gita Natarajan Shankar, Helen Jaber Parish
  • Patent number: RE42748
    Abstract: A composition for oral radionuclide chelation therapy comprises a DTPA chelate selected from Zn-DTPA and Ca-DTPA and a permeation enhancer that preferentially increases jejunal uptake of the DTPA chelate. The composition has a DTPA chelate bioavailability of at least 10% of the chelate when orally administered to a mammal.
    Type: Grant
    Filed: April 17, 2011
    Date of Patent: September 27, 2011
    Assignee: SRI International
    Inventors: Gita Natarajan Shankar, Helen Jaber Parish